Bank of Montreal’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Bank of Montreal’s Portfolio HTGM Stock Details HTGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-178	Closed	-$80K	–	5147
2019 Q1	$80K	Hold	178	–	–	﹤0.01%	3157
2018 Q4	$82K	Hold	178	–	–	﹤0.01%	3056
2018 Q3	$162K	Sell	178 -100	-36%	-$66K	﹤0.01%	2867
2018 Q2	$163K	Hold	278	–	–	﹤0.01%	2865
2018 Q1	$181K	Buy	+278	New	+$209K	﹤0.01%	2681

Other funds holding HTGM

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $385M AUM 31.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal's HTGM Position: Q2 2019 in Review

Bank of Montreal sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q2 2019, closing a stake of 178 shares — an estimated $80K sold.

Bank of Montreal first reported a position in HTGM in Q1 2018 and held it in 5 quarters. The position peaked at $181K in Q1 2018. 43 funds tracked by Wall St. Rank hold HTGM as of Q2 2019.

Bank of Montreal reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Bank of Montreal sold 178 HTG Molecular Diagnostics, Inc. Common Stock shares in Q2 2019, an estimated $80K.
Bank of Montreal first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q1 2018 and held it in 5 quarters.
Bank of Montreal's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $181K in Q1 2018.
43 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q2 2019.

Based on Bank of Montreal's 13F filing for Q2 2019, filed 9 Aug 2019.